{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:37:25Z","timestamp":1789846645795,"version":"4.0.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Osteoarthritis (OA) is a degenerative joint disease that causes pain, stiffness, and reduced mobility, significantly affecting the quality of life for millions globally. Current treatments focus on symptom management, with limited efficacy in addressing the underlying disease progression. Hypertonic dextrose prolotherapy (DPT) has emerged as a potential regenerative treatment, utilizing dextrose injections to stimulate the body\u2019s natural healing mechanisms by promoting tissue regeneration, strengthening ligaments, and improving joint function. Recent clinical studies, including the latest research findings, have shown that prolotherapy offers significant pain relief and functional improvement in knee OA, often outperforming other treatments like hyaluronic acid (HA) and corticosteroid injections. Despite promising results, the efficacy of prolotherapy varies across studies due to differences in protocols and study designs. Challenges remain, including lack of standardization, methodological bias, and short-term follow-up. Future research with rigorous designs and long-term follow-ups is necessary to establish prolotherapy\u2019s role in OA management, ensuring a more comprehensive understanding of its therapeutic potential.<\/jats:p>","DOI":"10.3389\/fendo.2025.1602727","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T04:10:20Z","timestamp":1754280620000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Hypertonic dextrose prolotherapy in osteoarthritis: mechanisms, efficacy, and future research directions"],"prefix":"10.3389","volume":"16","author":[{"given":"Kai","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0140-6736(24)02322-5","article-title":"Osteoarthritis","volume":"405","author":"Kloppenburg","year":"2025","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04838-y","article-title":"Prevalence of osteoarthritis in lower middle- and low-income countries: a systematic review and meta-analysis","volume":"41","author":"Yahaya","year":"2021","journal-title":"Rheumatol Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"10253","DOI":"10.1038\/s41598-025-95212-6","article-title":"Analysis of the current status and factors influencing post-traumatic stress disorder in elderly patients with knee osteoarthritis: a cross-sectional study","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-025-03153-3","article-title":"An up-to-date description of the use of non-steroidal anti-inflammatory drugs (NSAIDs) in Italy: evidence from real clinical practice","volume":"42","author":"Perrone","year":"2025","journal-title":"Adv Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12891-025-08402-8","article-title":"Efficacy and safety of fasinumab in an NSAID-controlled study in patients with pain due to osteoarthritis of the knee or hip","volume":"26","author":"DiMartino","year":"2025","journal-title":"BMC Musculoskelet Disord"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2025.03.037","article-title":"Limited satisfaction and increased risk with intra-articular corticosteroid injections in patients who have hip osteoarthritis needing total hip arthroplasty","volume":"40","author":"Metz","year":"2025","journal-title":"J Arthroplasty"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3635465241302820","DOI":"10.1177\/03635465241302820","article-title":"Mechanisms of action of intra-articular hyaluronic acid injections for knee osteoarthritis: a targeted review of the literature","author":"Sherman","year":"2025","journal-title":"Am J Sports Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3390\/jcm14041272","article-title":"Intra-articular hyaluronic acid for knee osteoarthritis: a systematic umbrella review","volume":"14","author":"Glinkowski","year":"2025","journal-title":"J Clin Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-024-06377-0","article-title":"Avascular necrosis or rapid destruction of the hip following hip intra-articular corticosteroid injections: a systematic review","volume":"49","author":"Zhao","year":"2025","journal-title":"Int Orthop"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jse.2024.05.025","article-title":"Preoperative corticosteroid injections are associated with a higher periprosthetic infection rate following primary total shoulder arthroplasty: a systematic review and meta-analysis","volume":"33","author":"Schoell","year":"2024","journal-title":"J Shoulder Elb Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00402-025-05816-w","article-title":"Cutting through infection risk: robotic-assisted vs. conventional total knee replacement surgery - a meta-analysis","volume":"145","author":"Desouza","year":"2025","journal-title":"Arch Orthop Trauma Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3109\/15360288.2012.734900","article-title":"Prolotherapy","volume":"26","author":"Goswami","year":"2012","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"B13","article-title":"Musculoskeletal therapies: musculoskeletal injection therapy","volume":"470","author":"Hulsopple","year":"2018","journal-title":"FP Essent"},{"key":"B14","first-page":"68","article-title":"Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity","volume":"6","author":"Reeves","year":"2000","journal-title":"Altern Ther Health Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2011.0030","article-title":"Hypertonic dextrose injections (prolotherapy) for knee osteoarthritis: results of a single-arm uncontrolled study with 1-year follow-up","volume":"18","author":"Rabago","year":"2012","journal-title":"J Altern Complement Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1504","article-title":"Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial","volume":"11","author":"Rabago","year":"2013","journal-title":"Ann Fam Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2016.0164","article-title":"Qualitative assessment of patients receiving prolotherapy for knee osteoarthritis in a multimethod study","volume":"22","author":"Rabago","year":"2016","journal-title":"J Altern Complement Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.01.053","article-title":"Advances in the pathology and treatment of osteoarthritis","volume":"30","author":"Peng","year":"2025","journal-title":"J Adv Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmr.2022.08.011","article-title":"Prolotherapy: A narrative review of mechanisms, techniques, and protocols, and evidence for common musculoskeletal conditions","volume":"34","author":"Hsu","year":"2023","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2011.02.008","article-title":"Effect of prolotherapy on cellular proliferation and collagen deposition in MC3T3-E1 and patellar tendon fibroblast populations","volume":"158","author":"Freeman","year":"2011","journal-title":"Transl Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2018.0866","article-title":"Prolotherapy: Potential for the treatment of chronic wounds","volume":"8","author":"Siadat","year":"2019","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06723-4","article-title":"A comparative analysis of prolotherapy efficacy in patients with knee osteoarthritis across varied dextrose concentrations","volume":"42","author":"Ozturk","year":"2023","journal-title":"Clin Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/02692155221086213","article-title":"Effectiveness, compliance, and safety of dextrose prolotherapy for knee osteoarthritis: A meta-analysis and metaregression of randomized controlled trials","volume":"36","author":"Chen","year":"2022","journal-title":"Clin Rehabil"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2520","article-title":"Efficacy of intra-articular hypertonic dextrose (prolotherapy) for knee osteoarthritis: a randomized controlled trial","volume":"18","author":"Sit","year":"2020","journal-title":"Ann Fam Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s42358-019-0083-7","article-title":"Prolotherapy for knee osteoarthritis using hypertonic dextrose vs other interventional treatments: systematic review of clinical trials","volume":"59","author":"Arias-V\u00e1zquez","year":"2019","journal-title":"Adv Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-2835","article-title":"Changes in levels of cartilage oligomeric proteinase and urinary C-terminal telopeptide of type II collagen in subjects with knee osteoarthritis after dextrose prolotherapy: A randomized controlled trial","volume":"53","author":"Waluyo","year":"2021","journal-title":"J Rehabil Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S215576","article-title":"Periarticular hypertonic dextrose vs intraarticular hyaluronic acid injections: a comparison of two minimally invasive techniques in the treatment of symptomatic knee osteoarthritis","volume":"11","author":"Hosseini","year":"2019","journal-title":"Open Access Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.3390\/ijms24076078","article-title":"Comparative efficacy of intra-articular injection, physical therapy, and combined treatments on pain, function, and sarcopenia indices in knee osteoarthritis: a network meta-analysis of randomized controlled trials","volume":"24","author":"Liao","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S147757","article-title":"The effects of injecting intra-articular platelet-rich plasma or prolotherapy on pain score and function in knee osteoarthritis","volume":"13","author":"Rahimzadeh","year":"2018","journal-title":"Clin Interv Aging"},{"key":"B30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3892\/mi.2023.105","article-title":"A comparison between hypertonic dextrose prolotherapy and conventional physiotherapy in patients with knee osteoarthritis","volume":"3","author":"Yildiz","year":"2023","journal-title":"Med Int (Lond)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13018-024-04762-4","article-title":"Demonstrating the effectiveness of intra-articular prolotherapy combined with peri-articular perineural injection in knee osteoarthritis: a randomized controlled trial","volume":"19","author":"Fu","year":"2024","journal-title":"J Orthop Surg Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.19082\/5663","article-title":"Comparative effectiveness of intra-articular prolotherapy versus peri-articular prolotherapy on pain reduction and improving function in patients with knee osteoarthritis: A randomized clinical trial","volume":"9","author":"Farpour","year":"2017","journal-title":"Electron Physician"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e140966","DOI":"10.5812\/aapm-140966","article-title":"Peri-articular dextrose prolotherapy: Investigating the effect of injection site on knee osteoarthritis pain: A double-blind, randomized, clinical trial","volume":"14","author":"Ebnerasooli","year":"2024","journal-title":"Anesth Pain Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2015.04.003","article-title":"Hypertonic dextrose injection (prolotherapy) for knee osteoarthritis: long term outcomes","volume":"23","author":"Rabago","year":"2015","journal-title":"Complement Ther Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e48096","DOI":"10.7759\/cureus.48096","article-title":"The effect of intra-articular hypertonic dextrose prolotherapy on pain, quality of life, and functional outcomes scores in patients with knee osteoarthritis","volume":"15","author":"Vomer","year":"2023","journal-title":"Cureus"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.18502\/ijaai.v19i3.3452","article-title":"Effect of dextrose prolotherapy, platelet rich plasma and autologous conditioned serum on knee osteoarthritis: A randomized clinical trial","volume":"19","author":"Pishgahi","year":"2020","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2019.0335","article-title":"The effects of dextrose prolotherapy in symptomatic knee osteoarthritis: A randomized controlled study","volume":"26","author":"Sert","year":"2020","journal-title":"J Altern Complement Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2013.0225","article-title":"Dextrose and morrhuate sodium injections (prolotherapy) for knee osteoarthritis: a prospective open-label trial","volume":"20","author":"Rabago","year":"2014","journal-title":"J Altern Complement Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/clinpract12060097","article-title":"Dextrose prolotherapy for symptomatic grade IV knee osteoarthritis: A pilot study of early and longer-term analgesia and pain-specific cytokine concentrations","volume":"12","author":"Topol","year":"2022","journal-title":"Clin Pract"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/MRR.0000000000000411","article-title":"Physical therapy, intra-articular dextrose prolotherapy, botulinum neurotoxin, and hyaluronic acid for knee osteoarthritis: randomized clinical trial","volume":"43","author":"Rezasoltani","year":"2020","journal-title":"Int J Rehabil Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2019.0341","article-title":"Effects of short wave diathermy added on dextrose prolotherapy injections in osteoarthritis of the knee","volume":"26","author":"\u0130\u015fik","year":"2020","journal-title":"J Altern Complement Med"},{"key":"B42","volume-title":"Regenerative Therapy In Pain","author":"Igwe","year":"2025"},{"key":"B43","doi-asserted-by":"publisher","first-page":"33921","DOI":"10.52965\/001c.33921","article-title":"A Comprehensive update of prolotherapy in the management of osteoarthritis of the knee","volume":"14","author":"Zhao","year":"2022","journal-title":"Orthop Rev (Pavia)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1602727\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T04:10:21Z","timestamp":1754280621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1602727\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":43,"alternative-id":["10.3389\/fendo.2025.1602727"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1602727","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"article-number":"1602727"}}